Bridging the Evidence-to-Policy Gap: Strengthening Capacities in Low- and Middle-Income Countries to Translate Antimicrobial Resistance Data and Evidence into Effective Policies
Open Access
- 1 March 2026
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 15 (3) , 255
Abstract
Background: The translation of antimicrobial resistance (AMR) data and evidence into policy remains limited in many low- and middle-income countries (LMICs) in Asia and Africa, despite expanded investments being made in AMR surveillance and research. This is due to fragmented governance, weak knowledge translation capacity, and insufficient multisectoral coordination. Results: Following the implementation of an Evidence-to-Policy (E2P) capacity-strengthening intervention in four LMICs in Africa and Asia, participant surveys showed improved confidence and capability to synthesize, interpret, and apply AMR evidence to inform policy. The four countries highlighted persistent constraints such as sectoral silos, limited institutional ownership, and gaps in evidence-use systems, but reported enhanced cross-sectoral collaboration and a clearer, replicable process for the development of Evidence Briefs for Policy (EBPs). Methodology: During Phase II of the Fleming Fund-resourced Regional AMR Data Analysis for Advocacy, Response, and Policy (RADAAR) project, a structured, hybrid, evidence-to-policy (E2P) capacity-strengthening model was implemented in Bhutan, Ghana, Kenya, and Lao People’s Democratic Republic, combining online and in-person training, targeted mentorship, and policymaker engagement. Each country developed a country-specific evidence brief for policy (EBP) and conducted policy dialogues to facilitate stronger decision maker involvement. Conclusions: RADAAR’s approach strengthened the foundational capacity for evidence-informed policymaking and demonstrated the value of institutionalized knowledge translation mechanisms. Sustained investment in E2P systems is essential to bridge the AMR E2P gap and ultimately support AMR prevention and control.Keywords
Funding Information
- Fleming Fund (FF133/539)
This publication has 37 references indexed in Scilit:
- Enablers and barriers for policymaker engagement in health research from the perspective of policymakers: a scoping reviewBMJ Open, 2025
- Pooling the complex survey data across the 64 lower and middle-income countries: A study on antibiotic usage in under-five childrenHeliyon, 2024
- Addressing Challenges in Antibiotic Access: Barriers, Implications and Strategies for SolutionPharmaceutical Medicine, 2024
- Fragmentation in One Health policy and practice responses to antimicrobial resistance and the salutary value of collaborative humilitySocial Theory & Health, 2024
- One Health governance principles for AMR surveillance: a scoping review and conceptual frameworkResearch Directions: One Health, 2024
- Evaluation of trends in hospital antimicrobial use in the Lao PDR using repeated point-prevalence surveys-evidence to improve treatment guideline useThe Lancet Regional Health - Western Pacific, 2022
- Antimicrobial use and resistance data in human and animal sectors in the Lao PDR: evidence to inform policyBMJ Global Health, 2021
- Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countriesClinical Microbiology and Infection, 2021
- Tackling antimicrobial resistance in low-income and middle-income countriesBMJ Global Health, 2019
- A multi-faceted approach to promote knowledge translation platforms in eastern Mediterranean countries: climate for evidence-informed policyHealth Research Policy and Systems, 2012